Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

A Functional Alternative Splicing Mutation in AIRE Gene Causes Autoimmune Polyendocrine Syndrome Type 1

  • Junyu Zhang ,

    Contributed equally to this work with: Junyu Zhang, Hongbin Liu

    Affiliations Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China

  • Hongbin Liu ,

    Contributed equally to this work with: Junyu Zhang, Hongbin Liu

    Affiliation Henan Provincial Corps Hospital, Chinese’s Armed Police Forces, Zhengzhou, China

  • Zhiyuan Liu,

    Affiliation Henan Provincial Corps Hospital, Chinese’s Armed Police Forces, Zhengzhou, China

  • Yong Liao,

    Affiliation Chongqing Municipal Corps Hospital, Chinese’s Armed Police Forces, Chongqing, China

  • Luo Guo,

    Affiliations Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China

  • Honglian Wang,

    Affiliations Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China

  • Lin He,

    Affiliations Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China

  • Xiaodong Zhang,

    Affiliations Neuroscience & Behavioral Disorders Program, Duke-NUS Graduate Medical School Singapore, Singapore, Department of Physiology, National University of Singapore, Singapore, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, United States of America

  • Qinghe Xing

    Affiliations Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China


Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare autosomal recessive disease defined by the presence of two of the three conditions: mucocutaneous candidiasis, hypoparathyroidism, and Addison’s disease. Loss-of-function mutations of the autoimmune regulator (AIRE) gene have been linked to APS-1. Here we report mutational analysis and functional characterization of an AIRE mutation in a consanguineous Chinese family with APS-1. All exons of the AIRE gene and adjacent exon-intron sequences were amplified by PCR and subsequently sequenced. We identified a homozygous missense AIRE mutation c.463G>A (p.Gly155Ser) in two siblings with different clinical features of APS-1. In silico splice-site prediction and minigene analysis were carried out to study the potential pathological consequence. Minigene splicing analysis and subsequent cDNA sequencing revealed that the AIRE mutation potentially compromised the recognition of the splice donor of intron 3, causing alternative pre-mRNA splicing by intron 3 retention. Furthermore, the aberrant AIRE transcript was identified in a heterozygous carrier of the c.463G>A mutation. The aberrant intron 3-retaining transcript generated a truncated protein (p.G155fsX203) containing the first 154 AIRE amino acids and followed by 48 aberrant amino acids. Therefore, our study represents the first functional characterization of the alternatively spliced AIRE mutation that may explain the pathogenetic role in APS-1.


Autoimmune polyendocrine syndrome type 1 (APS-1, OMIM 240300), formerly known as Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare but devastating primary immunodeficiency disorder, which usually manifests during childhood and adolescence [1], [2]. Clinical diagnosis for APS-1 typically requires the presence of at least two of the three hallmark conditions: chronic mucocutaneous candidiasis, hypoparathyroidism and Addison’s disease [2]. Mutations in autoimmune regulator (AIRE) gene have been linked to APS-1 [3], [4]. The AIRE gene encodes a 57 kDa transcription regulator of 545 amino acids involved in regulating autoimmunity by promoting the ectopic expression and presentation of tissue-restricted antigens during T-cell development in the thymus [5]. AIRE protein contains several distinct domains, such as a potential bipartite nuclear localization signals (NLS) consisting of amino acids 110–114 and 131–133, four interspersed LXXLL motifs, two plant homeodomain (PHD) fingers, caspase-recruitment domain (CARD), and SAND (named after Sp100, AIRE-1, NucP41/75, DEAF-1) domain [3], [4], [6], [7]. Consistent with these features, the AIRE protein is localized predominantly in the nucleus, where it potentially modulates the transcription of a variety of genes by interacting with specific DNA sequences and/or acting through epigenetic mechanisms [5], [6], [8].

Patients with APS-1 also routinely exhibit additional autoimmune diseases, including type 1 diabetes mellitus, hypothyroidism, vitiligo, alopecia, autoimmune hepatitis, pernicious anemia, and asplenism [9]. The range of these secondary disorders is broad and variable, affected siblings carrying the same mutations can develop divergent spectrums of autoimmune disorders [10]. To date, more than 70 different mutations of the AIRE gene have been identified in APS-1 patients, two major mutations (R257X and L323SfsX51) of which are responsible for 95% of the mutant alleles in APS-1 patients [11], [12], [13]. Although AIRE mutations are mostly autosomal recessive, an autosomal dominant mutation with distinct autoimmune phenotype has recently been identified [14]. However, it is noteworthy that few AIRE mutations have been functionally characterized [15]. Therefore, elucidating the functions of AIRE mutations will help to understand the pathophysiology of APS-1.

Here we report the identification of a missense mutation of AIRE in two siblings of a Chinese family. Moreover, functional characterization of the mutation suggested that this mutation resulted in alternative splicing of AIRE and a truncated protein with premature termination codon (PTC) downstream of exon 3 of AIRE.


Clinical Characteristics of APS-1 Patients in a Chinese Family

Two siblings with autosomal recessive APS-1 of a Chinese family have been examined in the study. They were born from healthy consanguineous parents of third cousins (Figure 1A). The pedigree comprised 13 individuals spanning five generations. The proband (IV-1) was a young man who was diagnosed with severe APS-1 symptoms including hypoparathyroidism, Addison’s disease, epilepsy, pernicious anemia, and chronic/tension headaches at age 18, and further developed keratopathy at age 19. At age 24, he was diagnosed with type 1 diabetes mellitus based on urine acetone body test and an increased blood glucose level (22.5 mmol/L). He died from diabetes complicated with keto acidosis 5 months later. In contrast, his sister (IV-3) who was also diagnosed with APS-1 showed mild clinical symptoms. Early signs of mucocutaneous candidiasis that can wax and wane were first appeared when she was only 1 year-old. She suffered transient Japanese encephalitis at age 7, and followed by additional symptoms, including hypoparathyroidism and epilepsy at age 15. The two patients also suffered recurrent carpopedal spasm, a common clinical manifestation of hypoparathyroidism. In contrast to her brother’s severe symptoms, the tetany has not recurred since she was age 21. The other living members of the family are healthy. A summary of the clinical manifestations of the patients are listed in Table 1.

Figure 1. Pedigree of the two patients with APS-1 and detection of the c.463G>A AIRE mutation.

(A) Pedigree of the Chinese family with APS-1. Numbered family members were subjected to mutational analysis. Genotypes were shown as wild-type (G/G), heterozygous (G/A) and homozygous (A/A) of the c.463G>A AIRE mutation. Arrow indicates the proband. (B) Direct sequence analysis of the AIRE gene identified homozygous carriers of c.463G>A mutation in patients, while heterozygous carriers were found in unaffected members (III-1, III-2, IV-2, V-1) of the family. Control and IV-4 carried wild-type AIRE. Arrow indicates the homozygous G>A mutation at the end of exon 3.

Identification of AIRE Mutation and in silico Splicing Assay

Based on the clinical features of the patients, which supported the diagnosis of APS-1, mutational screening of the AIRE gene was carried out. Direct sequencing of the AIRE gene revealed that the affected patients were homozygote for a missense mutation c.463G>A at the end of exon 3, which belongs to the conserved splice donor sequence [16] (Figure 1B). The mutation was also detected in heterozygous state in the other examined healthy family members except IV-4, but was not detected in 100 ethnically matched healthy control subjects. This mutation has been previously reported in a German girl with APS-1 and authors speculated that this mutation might cause a frameshift of AIRE by skipping exon 4 [17].

While ESEfinder ( [18] and SplicePort ( [19] predicted splice donor site in wild-type AIRE, the recognition of such splice donor site was severely attenuated in the presence of c.463G>A mutation.

The c.463G>A Mutation Generated an Aberrant Transcript Retained Intron 3

In order to evaluate the predicted results, we attempted to determine the exact consequence of the c.463G>A mutation in pre-mRNA splicing by in vitro splicing assay using a modified splicing reporter construct without the constitutively active adenovirus exonic sequences [20]. Two minigene constructs, harboring the wild-type and mutant AIRE fragments (1902-bp genomic DNA, spanning from AIRE exon 2 to exon 5) (Figure 2A), respectively, were generated. These two minigenes together with the vector were individually transfected into HeLa cells. Twenty-four hours after transfection, total RNA was extracted, reverse transcribed and amplified with primers (P1 and P2) located in exon 2 and exon 5 (Figure 2A). Differential splicing pattern was found between the cells transfected with wild-type and mutant minigenes (Figure 2B). While predicted 295-bp PCR fragment of normal splicing was shown and confirmed by sequencing analysis when wild-type minigene construct was expressed, an additional 678-bp PCR product was shown in the presence of mutant minigene construct. Sequencing analysis of the 678-bp amplicons revealed that this transcript was an alternatively spliced product which retained intron 3 (Figure 2B). Identical results were obtained using HEK293T cells (data not shown).

Figure 2. Alternative splicing of AIRE by the c.463G>A mutation.

(A) Schematic diagram of the AIRE minigene constructs. Complete genomic DNA spanning from exon 2 to exon 5 of AIRE gene was amplified from wild-type control and the APS-1 patient (homozygous for the c.463G>A mutation), respectively, for minigene analysis. P1 and P2 were exonic primers to evaluate the results of RT-PCR. (B) Minigene constructs were individually transfected into HeLa cells. RT-PCR products amplified with the primers (P1 and P2) showed an aberrant splicing pattern in mutant minigene compared with wild-type minigene. The predicted cDNA transcripts are shown, which was confirmed by DNA sequence analysis. * indicates the premature termination codon in intron 3. (C) RT-PCR analysis of AIRE mRNA from lymph node needle biopsy of a heterozygous carrier (III-1; G/A) and a healthy control (G/G) using the same primers of minigene analysis. A cDNA fragment of 295-bp, which corresponded to predicted wild-type transcript, was identified in both control and the heterozygous carrier of the c.463G>A mutation. In addition, a longer 678-bp transcript was identified in the heterozygous carrier. DNA sequence analysis of the 678-bp transcript revealed the retention of exon 3. (D) In vitro translation assay. Total cell lysates of HEK293T cells transfected with wild-type or intron 3-retaining AIRE were immunoblotted with FLAG antibody. Compared with the wild-type, the intron 3-retaining AIRE translated a shorted product. β-actin was used as an internal control.

AIRE mRNA has been detected in lymph node, while whether it can be detected in peripheral blood mononuclear cells (PBMCs) has still not been reached an agreement [21]. Thus, to further confirm our results, RT-PCR analysis of total RNA extracted from lymph node needle biopsy of a heterozygous carrier (III-1; G/A) and a healthy control (IV-4; G/G) was performed with the same primers of the minigene analysis. While a 295-bp transcript was detected in both the control and heterozygous subjects, consistent with the minigene analysis result in cell lines, we specifically detected an additional aberrant 678-bp fragment in the heterozygous subject (Figure 2C). cDNA sequence analysis confirmed the 295-bp and 678-bp transcripts as wild-type and intron 3-retaining transcript, respectively (Fig. 2C). It is worthwhile to note that aberrant pre-mRNA splicing was present at much reduced level in the heterozygous carrier. Quantification of the relative proportion of wild-type and aberrant AIRE mRNA in lymph node of the heterozygous carrier showed that the majority (89.6%) of mRNA transcripts were wild-type suggested that the presence of degradation by the nonsense-mediated mRNA decay (NMD) [22].

Intron 3 retention was predicted to generate a truncated protein (p.G155fsX203) containing the first 154 AIRE amino acids and followed by 48 aberrant amino acids and a premature termination codon (PTC). To investigate the translation of the intron 3-retaining AIRE transcript, we performed immunoblotting with whole-cell lysates of transiently transfected HEK293T cells overexpressing wild-type AIRE mRNA, or mutated AIRE mRNA with the mutation c.463G>A plus a retained intron 3. When the expression construct contained the wild-type AIRE, the N-terminally tagged FLAG-AIRE protein displayed the expected molecular weight. The intron 3-retaining AIRE translated an abnormal protein band corresponding to the expected truncated AIRE (Figure 2D). Thus, our data demonstrated that the c.463G>A mutation reduced normal splicing by generating an alternatively spliced intron 3-retaining transcript, which resulted in a truncated protein.


APS-1 is an autosomal recessive disorder caused by defective of the AIRE gene. The disease is highly prevalent in certain genetically isolated populations, such as Finns, Sardinians and Iranian Jews [23], but is rare in Chinese population [24]. In the present study, we identified two Chinese siblings, a brother and a sister, who carried the same homozygous recurrent mutation of the AIRE gene, but had different onset and pattern of clinical symptoms of APS-1. Although the brother developed severe APS-1, his sister had mild symptoms. Intriguingly, the Germany girl carrying the same homozygous mutation developed severe APS-1 with three major clinical features, as well as rheumatoid factor positive arthritis, autoimmune hepatitis, chronic diarrhea, vitiligo, and hypothyroidism [17]. Therefore, it is important to emphasize that this homozygous mutation alone is not sufficient to determine all the clinical phenotypes of APS-1, suggesting that other unknown genetic and/or environmental factors in addition to AIRE dysfunction may be responsible for the diverse clinical symptoms and disease severity of APS-1.

Coding nonsynonymous mutations are commonly studied for their pathological functions through altered amino acid sequences. However, approximately 50% of all point mutations responsible for genetic diseases result in aberrant pre-mRNA splicing [16]. Of the reported AIRE mutations in APS-1, missense or nonsense mutations were mostly described, while splicing mutations were less common [25], [26]. Instead of a traditional approach to study AIRE (Gly155Ser) missense mutation, here we identified the potential severe pathological consequence of c.463G>A mutation, for generating an aberrant transcript retaining intron 3 (Figure 2). Because G is predominantly the last nucleotide of mammalian exons, which forms the conserved exon-intron junction [16], the c.463G>A mutation at the end of exon 3 potentially compromised the recognition of canonical GU splice donor. We hypothesized that intron 3 retention was due to severely loss-of-recognition of intron 3 splice donor, making the downstream intron 4 splice donor a favorable recognition site. It is noteworthy that the intron 3-retaining transcript was detected at much lower level than wild-type transcript in the heterozygous carrier (Figure 2C). Due to the presence of a PTC within intron 3, it is possible that NMD may play a role [22]. To support this notion, minigene constructs, which did not possess an initiation start codon, yielded predominant intron 3-retaining transcript (Figure 2A). Also, the much lower level intron 3-retaining transcript might be due to more efficient PCR amplification of the shorter fragment (Figure 2C). In addition to c.463G>A mutation, there are two more AIRE mutations (c.462A>T [27] and c.463+2T>C [28]) in APS-1 have been identified near this splice donor site. However, it is yet to determine whether these mutations have any effect on AIRE splicing. It is likely that this splice donor site might be a sensitive mutational hotspot of the AIRE gene. Taken together, our results revealed novel mechanism of defects in transcriptional regulation (e.g., pre-mRNA splicing) of AIRE.

In conclusion, we report a missense AIRE mutation (c.463G>A) in two patients of a consanguineous Chinese family with different phenotypes of APS-1, and for the first time confirmed its pathogenetic role in altering AIRE pre-mRNA splicing (intron 3 retention) by minigene splicing analysis and subsequent cDNA sequencing. Our approach to study functional mutation at the genomic DNA level would widen the molecular spectrum of APS-1 and provide valuable insights into the molecular mechanisms underlying the pathophysiology of APS-1.

Materials and Methods

Ethics Statement

This study was approved by the Ethics Review Committee of Fudan University and conducted according to the Declaration of Helsinki Principles. Written informed consent was obtained from all participants, including the 100 healthy control individuals. The patient in this manuscript has given written informed consent (as outlined in the PLoS consent form) to publish these case details.


All subjects of this study were recruited from the outpatient department of Henan Provincial Corps Hospital. Peripheral blood samples were collected from 7 members of the pedigree (Figure 1A) as well as from 100 ethnically matched unrelated healthy controls. Genomic DNA was isolated from these samples according to standard techniques. Lymph node tissue samples from human inguinal region were obtained via needle biopsy of a heterozygous carrier (III-1; G/A) and a healthy control (IV-4; G/G).

Mutational and in silico Splicing Analyses

All 14 exons and their flanking intron sequences of AIRE were analysed by direct sequencing from PCR amplicons. Primers and PCR conditions are available upon request. The mutation was identified by comparing with the reported reference sequence (NM_000383.2) and further analyzed in the 100 control individuals.

Online splice-site and cDNA sequence prediction were carried out by ESEfinder ( and SplicePort ( Both wild-type sequence and altered sequence were analyzed. The prediction was performed using default settings.

Minigene Constructs and Minigene Splicing Assay

Wild-type and mutated fragments of AIRE (1902-bp genomic DNA, spanning from AIRE exon 2 to exon 5) were generated by PCR amplification from genomic DNA of normal individuals and the APS-1 patient, using the following primers: AIRE-EcoR I-F 5′-CCGGAATTCGAGACGCTTCATCTGAAGGAA-3′ and AIRE-Hind III-R 5′-CCCAAGCTTCTGACTCAAACACCTGCTGGAT-3′. The PCR fragments were digested with EcoR I and Hind III, and subsequently cloned into a modified version of the pcDNA3 minigene [20] and verified by sequencing analysis.

HeLa and HEK293T cell lines (Cell Resource Center of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) were used in cell transfection. Transient transfection was carried out using Lipofectamine 2000 (Life Technologies). Twenty-four hours after transfection, total RNAs were extracted using TRIzol Reagent (Life Technologies). After DNase I treatment (Thermo), the first strand cDNA was synthesized using RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo). The wild-type and alternative splice variants were amplified with the following primers, P1 5′-CCTGGACAGCTTCCCCAA-3′ and P2 5′- CATGGCCACAGCTCTCTG-3′ (Figure 2A).

RT-PCR Analysis of AIRE mRNA in Lymph Node

Total RNA was isolated from the lymph node needle biopsy of a heterozygous carrier (III-1; G/A) and a healthy control (IV-4; G/G) using ZR RNA MicroPrep Kit (Zymo Research). After DNase I treatment (Thermo), the first strand cDNA was synthesized using RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo). The subsequent cDNA fragments were amplified with the same primers of minigene analysis. PCR products were detected by 2% agarose gel electrophoresis and confirmed by sequencing with the same primers.

The fluorescence density of the ethidium bromide bands obtained following gel electrophoresis of RT-CR products was quantified under unsaturated condition using ImageJ (National Institutes of Health) [29].

In vitro Translation Assay

The construct expressing N-terminally tagged FLAG-AIRE was kindly provided by Dr. M. Matsumoto (University of Tokushima, Kuramoto, Tokushima, Japan) [30]. The Intron 3-retaining AIRE was generated by multiple ligating PCR fragments (Exon 1–3; Intron 3; Exon 4–14) into pCMV-Tag 2B (Agilent Technologies) digested with EcoR I and Sal I. The constructs were verified by DNA sequencing. The PCR fragments were amplified using primers:




For in vitro translation, wild-type AIRE construct and the intron 3-retaining AIRE construct were transfected into HEK293T respectively as described above. Antibodies used for immunoblotting: anti-FLAG (M20008S Abmart), anti-β-Actin (#4967 Cell Signaling Technologies).


We thank Dr. Jing Du from Shanghai Institute of Planned Parenthood Research for offering splicing vector.

Author Contributions

Conceived and designed the experiments: JZ HL LH XZ QX. Performed the experiments: JZ HL ZL YL LG HW. Analyzed the data: JZ HL ZL YL QX. Contributed reagents/materials/analysis tools: HL ZL YL XZ. Wrote the paper: JZ HL XZ QX.


  1. 1. Perheentupa J (2006) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91: 2843–2850.
  2. 2. Buzi F, Badolato R, Mazza C, Giliani S, Notarangelo LD, et al. (2003) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria? J Clin Endocrinol Metab 88: 3146–3148.
  3. 3. Aaltonen J, Bjorses P, Perheentupa J, HorelliKuitunen N, Palotie A, et al. (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17: 399–403.
  4. 4. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, et al. (1997) Positional cloning of the APECED gene. Nat Genet 17: 393–398.
  5. 5. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, et al. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395–1401.
  6. 6. Ilmarinen T, Melen K, Kangas H, Julkunen I, Ulmanen I, et al. (2006) The monopartite nuclear localization signal of autoimmune regulator mediates its nuclear import and interaction with multiple importin alpha molecules. FEBS J 273: 315–324.
  7. 7. Pitkanen J, Vahamurto P, Krohn K, Peterson P (2001) Subcellular localization of the autoimmune regulator protein: characterization of nuclear targeting and transcriptional activation domain. J Biol Chem 276: 19597–19602.
  8. 8. Johnnidis JB, Venanzi ES, Taxman DJ, Ting JP, Benoist CO, et al. (2005) Chromosomal clustering of genes controlled by the aire transcription factor. Proc Natl Acad Sci U S A 102: 7233–7238.
  9. 9. Michels AW, Gottlieb PA (2010) Autoimmune polyglandular syndromes. Nat Rev Endocrinol 6: 270–277.
  10. 10. Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, et al. (2002) AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 87: 2568–2574.
  11. 11. Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, et al. (2007) Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 92: 595–603.
  12. 12. Bjorses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, et al. (2000) Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 66: 378–392.
  13. 13. Akirav EM, Ruddle NH, Herold KC (2011) The role of AIRE in human autoimmune disease. Nat Rev Endocrinol 7: 25–33.
  14. 14. Su MA, Giang K, Zumer K, Jiang H, Oven I, et al. (2008) Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. J Clin Invest 118: 1712–1726.
  15. 15. Mathis D, Benoist C (2009) Aire. Annu Rev Immunol 27: 287–312.
  16. 16. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285–298.
  17. 17. von Schnurbein J, Lahr G, Posovszky C, Debatin KM, Wabitsch M (2008) Novel homozygous AIRE mutation in a German patient with severe APECED. J Pediatr Endocrinol Metab 21: 1003–1009.
  18. 18. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568–3571.
  19. 19. Dogan RI, Getoor L, Wilbur WJ, Mount SM (2007) SplicePort – an interactive splice-site analysis tool. Nucleic Acids Res 35: W285–W291.
  20. 20. Zhang X, Nicholls PJ, Laje G, Sotnikova TD, Gainetdinov RR, et al. (2011) A functional alternative splicing mutation in human tryptophan hydroxylase-2. Mol Psychiatry 16: 1169–1176.
  21. 21. Eldershaw SA, Sansom DM, Narendran P (2011) Expression and function of the autoimmune regulator (Aire) gene in non-thymic tissue. Clin Exp Immunol 163: 296–308.
  22. 22. Maquat LE (2004) Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5: 89–99.
  23. 23. Bjorses P, Aaltonen J, Vikman A, Perheentupa J, Ben-Zion G, et al. (1996) Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet. 59: 879–886.
  24. 24. Liu C, Shi Y, Yin H, Li H, Fan S, et al. (2010) Autoimmune regulator gene mutations in a Chinese family with autoimmune polyendocrinopathy syndrome type I. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 27: 18–22.
  25. 25. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, et al. (2009) The Human Gene Mutation Database: 2008 update. Genome Med 1: 13.
  26. 26. Keerthikumar S, Raju R, Kandasamy K, Hijikata A, Ramabadran S, et al. (2009) RAPID: Resource of Asian Primary Immunodeficiency Diseases. Nucleic Acids Res 37: D863–D867.
  27. 27. Podkrajsek KT, Milenkovic T, Odink RJ, Claasen-van Der Grinten HL, Bratanic N, et al. (2008) Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1. Eur J Endocrinol 159: 633–639.
  28. 28. Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD, et al. (1998) Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum Genet 103: 681–685.
  29. 29. Abràmoff MD, Magalhães PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics international 11: 36–42.
  30. 30. Akiyoshi H, Hatakeyama S, Pitkanen J, Mouri Y, Doucas V, et al. (2004) Subcellular expression of autoimmune regulator is organized in a spatiotemporal manner. J Biol Chem 279: 33984–33991.